About Us
Advocacy
Council
Committees
Early-Career Investigators
Sections
Awards
Grants
News
Newsletter
Annual Meeting
Obesity 2010
Journal: Obesity
Members
Join
Member Resources
Member Benefits
Member Directory
Membership Renewal
Calendar of Events
Other Professionals
Jobs
Funding
Education
CORE
Doubly Labeled Water
Obesity Online
Office Management of Obesity
Practical Guide
Certification
Body of Knowledge
FAQ
Obesity Information
Consumer Information
Fact Sheets
FAQ
Links
Statistics
Video Resources
Press
Media FAQ
|

Obesity Statistics
|
NIH Disease Funding table: Special Areas of Interest
This table displays the annual support level for various research, condition, and disease categories based on grants, contracts, and other
funding mechanisms used across the National Institutes of Health (NIH).
|
Research/Disease Areas
(Dollars in millions and rounded) |
FY 2005
(Actual) |
FY 2006
(Actual) |
FY 2007
(Actual - NIH
Historical Method) |
FY 2007
(Actual - NIH
Revised Method) |
FY 2008
(Actual) |
FY 2009
(Estimated) |
FY 2010
(Estimated) |
| Aging |
$2,415 |
$2,431 |
$2,462 |
$1,879 |
$1,965 |
$2,019 |
$2,045 |
| Alcoholism |
$512 |
$511 |
$521 |
$443 |
$452 |
$466 |
$473 |
| ALS |
$42 |
$44 |
$39 |
$40 |
$43 |
$44 |
$45 |
| Alzheimer's Disease |
$656 |
$643 |
$645 |
$411 |
$412 |
$423 |
$428 |
| Anorexia |
$14 |
$15 |
$12 |
$8 |
$7 |
$7 |
$7 |
| Anthrax |
$183 |
$150 |
$105 |
$160 |
$134 |
$137 |
$139 |
| Asthma |
$289 |
$283 |
$294 |
$252 |
$246 |
$252 |
$256 |
| Autism |
$102 |
$108 |
$127 |
$93 |
$118 |
$122 |
$141 |
| Autoimmune Disease |
$589 |
$598 |
$587 |
$759 |
$762 |
$783 |
$790 |
| Basic Behavioral and Social Science |
$1,065 |
$1,062 |
$1,104 |
$1,119 |
$1,149 |
$1,182 |
$1,198 |
| Behavioral and Social Science |
$3,044 |
$3,001 |
$3,060 |
$3,157 |
$3,215 |
$3,316 |
$3,362 |
| Bioengineering |
$1,318 |
$1,546 |
$1,469 |
$2,610 |
$2,853 |
$2,932 |
$2,973 |
| Biotechnology |
$10,889 |
$9,974 |
$9,814 |
$5,344 |
$5,179 |
$5,390 |
$5,468 |
| Brain Cancer |
$157 |
$178 |
$193 |
$204 |
$194 |
$200 |
$205 |
| Brain Disorders |
$4,784 |
$4,732 |
$4,670 |
$3,592 |
$3,729 |
$3,835 |
$3,888 |
| Breast Cancer |
$700 |
$718 |
$707 |
$729 |
$726 |
$748 |
$769 |
| Cancer |
$5,639 |
$5,575 |
$5,643 |
$5,549 |
$5,570 |
$5,748 |
$6,016 |
| Cardiovascular |
$2,333 |
$2,349 |
$2,370 |
$1,942 |
$2,027 |
$2,081 |
$2,103 |
| Cervical Cancer |
$96 |
$97 |
$96 |
$67 |
$69 |
$71 |
$73 |
| Child Abuse and Neglect Research |
$40 |
$38 |
$38 |
$41 |
$30 |
$31 |
$32 |
| Childhood Leukemia |
$60 |
$53 |
$55 |
$50 |
$39 |
$40 |
$41 |
| Chronic Fatigue Syndrome |
$5 |
$5 |
$4 |
$4 |
$4 |
$4 |
$3 |
| Chronic Obstructive Pulmonary Disease |
$63 |
$67 |
$91 |
$72 |
$75 |
$78 |
$79 |
| Clinical Research |
$8,719 |
$8,785 |
$9,116 |
$9,862 |
$9,629 |
$9,931 |
$10,086 |
| Clinical Trials |
$2,863 |
$2,767 |
$2,949 |
$3,422 |
$3,562 |
$3,663 |
$3,719 |
| Complementary and Alternative Medicine |
$306 |
$301 |
$299 |
$426 |
$430 |
$443 |
$450 |
| Conditions affecting unborn children |
$108 |
$103 |
$110 |
$81 |
$81 |
$83 |
$84 |
| Cystic Fibrosis |
$89 |
$85 |
$82 |
$78 |
$90 |
$93 |
$94 |
| Dental/Oral and Craniofacial Disease |
$415 |
$413 |
$417 |
$484 |
$463 |
$476 |
$483 |
| Depression |
$329 |
$335 |
$345 |
$398 |
$402 |
$412 |
$418 |
| Diabetes 2/ |
$1,055 |
$1,038 |
$1,037 |
$1,069 |
$1,080 |
$1,104 |
$1,110 |
| Diagnostic Radiology |
$788 |
$712 |
$694 |
$1,046 |
$1,095 |
$1,125 |
$1,142 |
| Digestive Diseases |
$1,237 |
$1,252 |
$1,234 |
$1,460 |
$1,426 |
$1,466 |
$1,487 |
| Digestive Diseases - (Gallbladder) |
$7 |
$7 |
$6 |
$6 |
$7 |
$7 |
$7 |
| Digestive Diseases - (Peptic Ulcer) |
$18 |
$17 |
$23 |
$15 |
$14 |
$14 |
$14 |
| Drug Abuse (NIDA Only) 3/ |
$1,006 |
$990 |
$1,001 |
$1,001 |
$1,007 |
$1,033 |
$1,045 |
| Endometriosis |
$10 |
$12 |
$12 |
$12 |
$15 |
$15 |
$16 |
| Epilepsy |
$105 |
$103 |
$105 |
$145 |
$145 |
$150 |
$152 |
| Estrogen |
$183 |
$153 |
$164 |
$283 |
$245 |
$252 |
$256 |
| Fetal Alcohol Syndrome |
$28 |
$29 |
$34 |
$32 |
$34 |
$35 |
$35 |
| Fibroid Tumors (Uterine) |
$15 |
$15 |
$14 |
$20 |
$16 |
$17 |
$17 |
| Fibromyalgia |
$10 |
$9 |
$9 |
$11 |
$12 |
$13 |
$13 |
| Food Safety |
$329 |
$316 |
$278 |
$230 |
$244 |
$250 |
$253 |
| Gene Therapy |
$355 |
$356 |
$325 |
$250 |
$249 |
$255 |
$259 |
| Gene Therapy Clinical Trials |
$31 |
$32 |
$31 |
$12 |
$16 |
$16 |
$17 |
| Genetic Testing |
$422 |
$417 |
$395 |
$402 |
$383 |
$395 |
$402 |
| Genetics |
$4,840 |
$4,878 |
$4,878 |
$7,000 |
$6,872 |
$7,066 |
$7,173 |
| Global Warming Climate Change |
$24 |
$58 |
$56 |
$1 |
$1 |
$1 |
$1 |
| Health Disparities 4/ |
$2,699 |
$2,766 |
$2,744 |
$2,744 |
$2,614 |
$2,691 |
$2,725 |
| Health Services |
$940 |
$929 |
$1,023 |
$730 |
$743 |
$779 |
$792 |
| Heart Disease |
$2,087 |
$2,087 |
$2,126 |
$1,126 |
$1,217 |
$1,249 |
$1,263 |
| Heart Disease - Coronary Heart Disease |
$397 |
$398 |
$382 |
$379 |
$367 |
$377 |
$381 |
| Hematology |
$1,122 |
$1,114 |
$1,128 |
$881 |
$894 |
$919 |
$935 |
| Hepatitis |
$179 |
$177 |
$174 |
$176 |
$180 |
$185 |
$187 |
| HIV/AIDS 5/ |
$2,921 |
$2,902 |
$2,906 |
$2,906 |
$2,928 |
$3,010 |
$3,055 |
| HPV and/or Cervical Cancer Vaccines |
$16 |
$14 |
$20 |
$16 |
$19 |
$19 |
$20 |
| Human Genome |
$1,084 |
$1,065 |
$1,099 |
$1,246 |
$1,259 |
$1,297 |
$1,317 |
| Hypertension |
$371 |
$395 |
$390 |
$231 |
$263 |
$270 |
$273 |
| Immunization |
$1,438 |
$1,438 |
$1,342 |
$1,713 |
$1,734 |
$1,779 |
$1,804 |
| Infectious Diseases |
$3,188 |
$3,132 |
$3,059 |
$3,433 |
$3,575 |
$3,678 |
$3,725 |
| Infertility |
$40 |
$40 |
$51 |
$65 |
$73 |
$75 |
$76 |
| Influenza |
$164 |
$207 |
$271 |
$280 |
$204 |
$209 |
$212 |
| Lung Cancer |
$289 |
$266 |
$249 |
$164 |
$169 |
$175 |
$179 |
| Lymphoma |
$177 |
$170 |
$158 |
$186 |
$193 |
$199 |
$204 |
| Mental Health |
$1,848 |
$1,824 |
$1,853 |
$2,061 |
$2,086 |
$2,142 |
$2,173 |
| Minority Health 4/ |
$2,404 |
$2,423 |
$2,407 |
$2,407 |
$2,396 |
$2,474 |
$2,508 |
| Multiple Sclerosis |
$110 |
$110 |
$98 |
$149 |
$169 |
$173 |
$176 |
| Muscular Dystrophy |
$40 |
$40 |
$47 |
$58 |
$56 |
$58 |
$59 |
| Neurosciences |
$4,902 |
$4,830 |
$4,809 |
$5,102 |
$5,224 |
$5,372 |
$5,444 |
| Nutrition |
$1,072 |
$1,039 |
$1,075 |
$1,327 |
$1,391 |
$1,429 |
$1,444 |
| Obesity |
$519 |
$594 |
$661 |
$595 |
$664 |
$681 |
$687 |
| Osteoporosis |
$191 |
$169 |
$164 |
$167 |
$183 |
$188 |
$190 |
| Ovarian Cancer |
$106 |
$102 |
$103 |
$89 |
$96 |
$99 |
$102 |
| Parkinson's Disease |
$225 |
$208 |
$187 |
$143 |
$152 |
$156 |
$158 |
| Pediatric 9/ |
$3,210 |
$3,161 |
$3,173 |
$2,622 |
$2,771 |
$2,864 |
$2,906 |
| Pediatric AIDS 7/ |
$279 |
$276 |
$262 |
$262 |
$241 |
$255 |
$260 |
| Pediatric Research Initiative 10/ |
$145 |
$141 |
$171 |
** |
$209 |
$212 |
$215 |
| Perinatal - Birth - Preterm (LBW) |
$394 |
$374 |
$351 |
$181 |
$197 |
$203 |
$206 |
| Perinatal - Neonatal Respiratory Distress Syndrome |
$10 |
$8 |
$9 |
$23 |
$18 |
$19 |
$19 |
| Perinatal Period - Conditions Originating in Perinatal Period |
$429 |
$407 |
$387 |
$413 |
$449 |
$461 |
$467 |
| Pneumonia & Influenza |
$317 |
$351 |
$405 |
$382 |
$295 |
$303 |
$307 |
| Polycystic Kidney Disease |
$25 |
$32 |
$36 |
$33 |
$41 |
$42 |
$42 |
| Prevention |
$7,100 |
$6,815 |
$6,729 |
$4,596 |
$4,623 |
$4,752 |
$4,822 |
| Prostate Cancer |
$373 |
$348 |
$345 |
$295 |
$290 |
$299 |
$307 |
| Regenerative Medicine |
$591 |
$614 |
$575 |
$697 |
$723 |
$743 |
$753 |
| Rehabilitation |
$325 |
$324 |
$344 |
$379 |
$403 |
$415 |
$421 |
| Schizophrenia |
$353 |
$364 |
$358 |
$220 |
$249 |
$256 |
$259 |
| Scleroderma |
$11 |
$11 |
$12 |
$12 |
$20 |
$21 |
$21 |
| Septicemia |
$42 |
$49 |
$49 |
$93 |
$95 |
$98 |
$99 |
| Sexually Transmitted Diseases/Herpes |
$252 |
$264 |
$288 |
$282 |
$245 |
$251 |
$255 |
| Sickle Cell Disease |
$91 |
$91 |
$94 |
$78 |
$80 |
$83 |
$83 |
| Small Pox |
$187 |
$149 |
$122 |
$142 |
$94 |
$97 |
$98 |
| Smoking and Health |
$533 |
$517 |
$534 |
$324 |
$310 |
$319 |
$325 |
| Spina Bifida |
$10 |
$11 |
$9 |
$14 |
$15 |
$16 |
$16 |
| Stem Cell Research |
$609 |
$643 |
$657 |
$968 |
$938 |
$963 |
$977 |
| Stroke |
$342 |
$342 |
$340 |
$288 |
$296 |
$305 |
$310 |
| Substance Abuse 8/ |
$1,508 |
$1,490 |
$1,523 |
$1,636 |
$1,763 |
$1,811 |
$1,836 |
| Topical Microbicides |
$66 |
$88 |
$99 |
$92 |
$102 |
$104 |
$105 |
| Tourette Syndrome |
$13 |
$13 |
$11 |
$9 |
$8 |
$9 |
$9 |
| Transmissible Spongiform Encephalopathy (TSE) |
$37 |
$35 |
$43 |
$50 |
$44 |
$45 |
$45 |
| Transplantation |
$545 |
$551 |
$534 |
$544 |
$519 |
$533 |
$540 |
| Tuberculosis |
$158 |
$150 |
$166 |
$188 |
$142 |
$145 |
$147 |
| Uterine Cancer |
$39 |
$28 |
$22 |
$24 |
$16 |
$16 |
$17 |
| Vaccine Related |
$1,450 |
$1,449 |
$1,358 |
$1,659 |
$1,632 |
$1,675 |
$1,698 |
| West Nile Virus |
$43 |
$85 |
$69 |
$81 |
$39 |
$40 |
$41 |
| Women's Health 4/ |
$3,551 |
$3,498 |
$3,470 |
$3,470 |
$3,514 |
$3,627 |
$3,683 |
| [-] |
Data is not available at this time. FY 2009 and FY 2010 estimates will be displayed upon transmittal of the President’s budget request or as otherwise directed by the U.S. Office of Management & Budget (OMB). |
| [*] |
The minimum reporting threshold for a specific disease/condition is $500,000. Reporting of $0 does not indicate that no research is being conducted. |
| [**] |
No methodology was identified for RCDC in 2007; therefore there is no data available under the “FY 2007 NIH Revised Method” column. |
| 2/ |
Includes research funded from the Type 1 diabetes appropriation. |
| 3/ |
Reporting for this category does not follow the standard RCDC process. Spending is reported consistent with U.S. Office of National Drug Control Policy (ONDCP) requirements (Only NIDA). More information on this area is available at http://www.nida.nih.gov/drugpages.html. |
| 4/ |
Reporting for this category does not follow the standard RCDC process. This category assigns project funding according to populations tracked by gender or ethnicity. The databases used to track gender/ethnicity are complex and not currently compatible with the RCDC system. |
| 5/ |
Reporting for this category does not follow the standard RCDC process. These are project listings only and non-project or other support costs associated with the annual total for the category are not included. More information on this area is available at http://www.oar.nih.gov/. |
| 7/ |
Reporting for this category does not follow the standard RCDC process. These are project listings only and non-project or other support costs associated with the annual total for the category are not included. More information on the budget associated with the category is available at http://www.oar.nih.gov/. Research reported for this category is also captured under the broader HIV/AIDS category. |
| 8/ |
Reporting for this category does not follow the standard RCDC process. This category includes all spending reported under the Drug Abuse category as well as projects categorized under the broader area of Substance Abuse. These are project listings only. More information on this area is available at http://www.nida.nih.gov/drugpages.html. |
| 9/ |
The reported total displayed in the "FY 2007 Actual-Historical Method" column does not include $69 million associated with the National Children's Study later identified to this category during development of subsequent reports. The recast FY 2007 total for this category that fully accounts for spending under the historical method is approximately $3,242 million. |
| 10/ |
The reported total displayed in the "FY 2007 Actual-Historical Method" column does not include $25.8 million later identified to this category during development of subsequent reports. The recast FY 2007 total for this category that fully accounts for spending under the historical method is approximately $197 million. |
Source: http://report.nih.gov/rcdc/categories/
Executive Office: 8630 Fenton Street, Suite 814, Silver Spring, MD 20910 | Tel: (301) 563-6526 | Fax: (301) 563-6595
2010 The Obesity Society. All rights reserved. Privacy Policy. Terms and Conditions.
Copyright © 2010
|